Pulse check as a tool to raise awareness of atrial fibrillation in pharmacies in the Czech Republic – a pilot project

Download PDF Česká verze

Authors: K. Malá-Ládová ^1,2,3; A. Patková ^1,2; J. Šolínová ^2,4; F. Alves Da Costa ^3,5
Authors place of work: Katedra sociální a klinické farmacie, Farmaceutická fakulta v Hradci Králové, Univerzita Karlova ¹; Sekce klinické farmacie, Česká farmaceutická společnost ČLS JEP, z. s. ²; International Pharmacists for Anticoagulation Care Taskforce ³; Lékárna U Zlatého hada, Cvikov ⁴; Research Institute for Medicines (iMED. ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Portugalsko ⁵
Published in the journal: Čes. slov. Farm., 2019; 68, 198-203
Category: Původní práce

Summary

Objective: The aim of the study was to raise the awareness of atrial fibrillation (AF) and the importance of pulse check in Czech pharmacies as well as to point out further possibilities of developing consulting activities in pharmacies.

Method: Our project was performed as part of a worldwide campaign during three weeks: Heart Rhythm Week (06/2017) and Atrial Fibrillation Awareness Week (11/2017, 11/2018). Pharmacies actively providing indi-vidual counselling offered manual pulse check to patients aged ≥ 40 years without chronic anticoagulant therapy. Whenever high risk of AF was observed, patients were referred to a physician for further evaluation.

Results: Pharmacists undertook pulse checks in 187 patients (mean age 59.0 ± 12.3 years; 70.6% women) in 14 participating pharmacies. The most common symptoms were fatigue (42.2%) and palpitations (20.9%), however, 40.6% of patients were asymptomatic. The mean heart rate was 73.2 ± 11.3 beats per minute (min. 51; max. 135) and irregular pulse was observed in 4.3% patients. The average CHA₂DS₂-VASc score was 2.0 ± 1.3. Eight (4.3%) patients were referred to a physician and in 5 patients (2.7%) the arrhythmia was diagnosed.

Conclusion: Czech pharmacies have successfully adopted this campaign, are interested in continuity of the project and may thus contribute to raise awareness of AF.

Keywords:

pharmacy – pharmacist – atrial fibrillation – pulse check

Zdroje

1. di Nisio M., van Es N., Büller H. R. Deep vein thrombosis and pulmonary embolism. Lancet 2016; 388(10063), 3060–3073.

2. Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B., Castella M., Diener H. C., Heidbuchel H., Hendriks J., Hindricks G., Manolis A. S., Oldgren J., Popescu B. A., Schotten U., Van Putte B., Vardas P., ESC Scientific Document Group. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart. J. 2016; 37(38), 2893–2962.

3. Maly J., Dvorackova S., Zimcikova E., Kubena A. A., Kolar J., Vlcek J., Penka M., Mala-Ladova K. Patterns in anticoagulant utilization in the Czech Republic during 2007–2017. J. Thromb. Thrombolysis 2019; 47(2), 305–311.

4. Svennberg E., Engdahl J., Al-Khalili F., Friberg L., Frykman V., Rosengvist M. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study. Circulation 2015; 131, 2176–2184.

5. Česká lékárnická komora. Doporučené postupy České lékárnické komory pro konzultační činnost v lékárnách. Dostupné z: https://www.lekarnici.cz/Vzdelavani/Doporucene-postupy/Doporucene-postupy-pro-konzultacni-cinnost-v-lekar.aspx (5. 6. 2019).

6. Šolínová J., Malý J. Individuální konzultace poskytované starší pacientce ve veřejné lékárně. Prakt. Lékáren. 2015; 11(2), 64–67.

7. Lowres N., Neubeck L., Salkeld G., Krass I., McLachlan A. J., Redfern J., Bennett A. A., Briffa T., Bauman A., Martinez C., Wallenhorst C., Lau J. K., Brieger D. B., Sy R. V., Freedman S. B. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb. Haemost. 2014; 111, 1167–1176.

8. Lowres N., Krass I., Neubeck L., Redfern J., McLachlan A. J., Bennett A. A., Freedman S. B. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation. Int. J. Clin. Pharm. 2015; 37, 1111–1120.

9. Shaw J., Harrison J., Harrison J. A community pharmacist-led anticoagulation management service: attitudes towards a new collaborative model of care in New Zealand. Int J. Pharm. Pract. 2014; 22, 397–406.

10. Sandhu R. K., Dolovich L., Deif B., Barake W., Agarwal G., Grinvalds A., Lim T., Quinn F. R., Gladstone D., Conen D., Connolly S. J., Healey J. S. High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme. Open Heart 2017; 3(2), e000515.

11. Twigg M. J., Thornley T., Scobie N. Identification of patients with atrial fibrillation in UK community pharmacy: an evaluation of a new service. Int. J. Clin. Pharm. 2016; 38(4), 784–787.

12. da Costa A. F., Antoniou S., Papastergiou J., Murillo M. D., Lobban T., Ladova K., Lee V. WY., Williams H., Griffiths D., Tous S., Breakwell N., Chaumais M. C. Value of pharmacists in detecting atrial fibrillation during World Heart Rhytm Week. European Society of Clinical Pharmacy. Heidelberg 2017 (konference abstrakt).

13. Lip G. Y., Nieuwlaat R., Pisters R., Lane D. A., Crijns H. J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137(2), 263–272.

14. Lowres N., Neubeck L., Redfern J., Freedman S. B. Screening to identify unknown atrial fibrillation. A systematic review. Thromb. Haemost. 2013; 110(2), 213–222.

15. Proietti M., Mairesse G. H., Goethals P., Scavee C., Vijgen J., Blankoff I., Vandekerckhove Y., Lip G. Y. A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. Europace 2016; 18(12), 1779–1786.

16. Freedman B., AF-Screen Collaborators. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation 2017; 135(19), 1851–1867.

17. Benito L., Coll-Vinent B., Gómez E., Martí D., Mitjavila J., Torres F., Miró Ò., Sisó A., Mont L. EARLY: a pilot study on early diagnosis of atrial fibrillation in a primary healthcare centre. Europace 2015; 17(11), 1688–1693.

18. AF Association. Know Your Pulse – Arrhythmia Alliance Group. Dostupné z: http://www.heartrhythmalliance.org/afa/uk/know-your-pulse (26. 6. 2019).

19. Papastergiou J., Kheir N., Ladova K., Rydant S., de Rango F., Antoniou S., Viola R., Murillo M. D., Steurbaut S., da Costa F. A. Pharmacists’ confidence when providing pharmaceutical care on anticoagulants, a multinational survey. Int. J. Clin. Pharm. 2017; 39(6), 1282–1290.